Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: Insights from an observational cohort study

BMC Cardiovascular Disorders

Volumn 18, Issue 1, 2018, Pages

  González Costello, José ^a   Comín Colet, Josep ^a   Lupón, Josep ^c   Enjuanes, Cristina ^b   De Antonio, Marta ^c   Fuentes, Lara ^a   Moliner Borja, Pedro ^b   Farré, Nuria ^b   Zamora, Elisabet ^c   Manito, Nicolás ^a   Pujol, Ramón ^a   Bayés Genis, Antoni ^c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Chronic heart failure; Hospitalization; Iron deficiency; Mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FERRITIN; HEMOGLOBIN; TRANSFERRIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITAL ADMISSION; INCIDENCE; IRON DEFICIENCY ANEMIA; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SPAIN; TIME FACTOR;

AGED; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; CAUSE OF DEATH; CHRONIC DISEASE; COMORBIDITY; FEMALE; FERRITINS; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 85055804267     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-018-0942-x     Document Type: Article

References (28)

1. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartman O, Ponikowska B, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872-80.
2. Klip IT, Jankowska EA, Enjuanes C, Voors AA, Banasiak W, Bruguera J, et al. The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences. Eur J Heart Fail. 2014;16:655-62.
3. Parikh A, Natarajan S, Lipsitz SR, Katz SD. Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and nutrition examination survey III. Prevalence and association with anaemia and inflammation. Circ Heart Fail. 2011;4:599-606.
4. González-Costello J, Comin-Colet J. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial. Eur J Heart Fail. 2010;12:1159-62.
5. Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, et al. Iron status in patients with chronic heart failure. Eur Heart J. 2013;34:827-34.
6. Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, et al. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J. 2017;38:362-72.
7. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker M, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency. The IRONOUT HF randomized clinical trial. JAMA. 2017;317:1958-66.
8. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436-48.
9. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2014;36:657-68.
10. Jankowska EA, Tkaczyszyn M, Suchocki T, Drozd M, von Haeling S, Doehner W, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. 2016;18:786-95.
11. Van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Bohm M, Doletsky A, et al. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017;136:1374-83.
12. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. Guidelines for the diagnosis and treatment of acute and chronic heart failure. The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200.
13. Wu A. Tietz Clinical Guide to Laboratory Tests. 4th ed. St Louis, MO: Saunders Elsevier; 2006. p. 56-61.
14. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165:575-82.
15. Lupón J, de Antonio M, Vila J, Peñafiel J, Galán A, Zamora E, et al. Development of a novel heart failure risk tool: the Barcelona bio-heart failure risk calculator (BCN bio-HF calculator). PLoS One. 2014;9:e85466.
16. Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Oleskowska-Florek W, et al. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J. 2014;35:2468-76.
17. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428-34.
18. Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail. 2001;3:283-91.
19. Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Meroño O, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013;15:1164-72.
20. Crespo-Leiro MG, Segovia-Cubero J, González-Costello J, Bayes-Genis A, López-Fernández S, Roig E, et al. Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry. Rev Esp Cardiol. 2015;68:785-93.
21. Lund LH, Donal E, Oger E, Hage C, Persson H, Haugen-Löfman I, et al. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16:992-1001.
22. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, et al. Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med. 2008;264:361-9.
23. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol. 2008;101:353-8.
24. Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the valsartan in acute myocardial infarction trial (VALIANT). Eur J Heart Fail. 2009;11:292-8.
25. Núñez J, Comín-Colet J, Miñana G, Núñez E, Santas E, Mollar A, et al. Iron deficiency and risk of early readmission following hospitalization for acute heart failure. Eur J Heart Fail. 2016;18:798-802.
26. Filippatos G, Farmakis D, Comin Colet J, Dickstein K, Lüscher TF, Willenheimer R, et al. Intravenous ferric carboxymaltose in iron deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail. 2013;15:1267-76.
27. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013;34:816-29.
28. Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol. 2011;154:289-30.